Prospective Neurocognitive Outcomes in Patients with 5 to 50 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e840-e841
DOI: 10.1016/j.ijrobp.2026.06.3111 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von C.L. Tseng und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tseng, C., Soliman, H., Detsky, J., Chen, H., Heyn, C., Maralani, P., Lipsman, N., Das, S., Perry, J., Ruschin, M., Wefel, J., & Sahgal, A. (2026). Prospective Neurocognitive Outcomes in Patients with 5 to 50 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), e840-e841. https://doi.org/10.1016/j.ijrobp.2026.06.3111
Vancouver
Tseng C, Soliman H, Detsky J, Chen H, Heyn C, Maralani P, et al. Prospective Neurocognitive Outcomes in Patients with 5 to 50 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e840-e841. doi:10.1016/j.ijrobp.2026.06.3111
BibTeX
@article{Tseng2026,
author = {Tseng, C.L. and Soliman, H. and Detsky, J. and Chen, H. and Heyn, C. and Maralani, P. and Lipsman, N. and Das, S. and Perry, J. and Ruschin, M.E. and Wefel, J.S. and Sahgal, A.},
title = {Prospective Neurocognitive Outcomes in Patients with 5 to 50 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e840--e841},
doi = {10.1016/j.ijrobp.2026.06.3111}
}
EUVIMED